Safety Study of Abatacept to Treat Refractory Sarcoidosis

NCT00739960 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Funding has been pulled

Conditions

Sarcoidosis

Interventions

DRUG: Abatacept

Sponsor

University of Chicago

Collaborators

[object Object]